Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

6.77
Delayed Data
As of 12:46pm ET
 -0.0484 / -0.71%
Today’s Change
4.45
Today|||52-Week Range
9.74
+26.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues800.0K1.4M4.3M6.9M
 
 
 
 
 
Depreciation And Amortization738.0K462.0K357.0K--
 
 
 
 
 
Operating ExpensesGross Income--911.0K----
 
 
General Expenses55.3M44.4M114.1M172.2M
 
 
 
 
 
Research And Development41.8M32.7M96.8M157.8M
 
 
 
 
 
Total Operating Expenses56.0M44.9M114.4M172.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-55.2M-43.5M-110.1M-165.3M
 
 
 
 
 
Extraordinary Credit1.2M11.7M0.00--
 
 
 
Extraordinary Charge-1.7M0.00-10.0M-124.0K
 
 
 
 
Other Expenses-1.4M-5.0K12.0K134.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-57.1M-31.8M-120.1M-165.3M
 
 
 
 
 
Preferred Dividend0.000.000.00-7.1M
 
 
Net Income-57.1M-31.8M-120.1M-165.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS85.9M101.1M125.4M130.4M
 
 
 
 
 
Shares To Calculate EPS Diluted85.9M101.1M125.4M130.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.66-$0.31-$0.96-$1.32
 
 
 
 
 
EPS Diluted-$0.66-$0.31-$0.96-$1.32